CHUGAI PHARMACEUTICAL CO., LTD. (4519) Other
Market cap
¥14.42T
P/E ratio
35.2x
Chugai Pharmaceutical develops and sells prescription medicines in Japan and internationally, with research operations spanning the US, Europe, and Asia.
| 2011/12 | 2012/12 | 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | 2025/12 | |
| Return on Assets | - | - | - | - | 9.4 | 7.9 | 10.2 | 11.2 | 15.9 | 18.7 | 21.8 | 22 | 17.1 | 18.7 | 18.6 |
| Return on equity (%) | - | - | - | ||||||||||||
| Employees | 6,779 | 6,836 | 6,872 | 7,023 | 7,169 | 7,245 | 7,372 | 7,432 | 7,394 | 7,555 | 7,664 | 7,771 | 7,604 | 7,778 | 7,872 |